By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tonix Pharmaceuticals, Inc. 

509 Madison Ave.
Suite 306
New York  New York  10022  U.S.A.
Phone: 212-980-9155 Fax: 212-923-5700




Company News
Tonix Pharma (TNXP) Prices $5.2 Million Underwritten Public Offering 10/26/2016 8:13:09 AM
Tonix Pharma (TNXP) Announces Proposed Underwritten Public Offering Of Common Stock And Warrants 10/26/2016 7:55:21 AM
Tonix Pharma (TNXP) To Host Posttraumatic Stress Disorder (PTSD) Awareness Day 10/19/2016 7:52:12 AM
Tonix Pharma (TNXP) To Present At Dawson James Securities 2016 Small Cap Growth Stock Conference 10/13/2016 7:57:26 AM
Tonix Pharma (TNXP) To Present At 16th Annual Sachs Biotech In Europe Forum 9/26/2016 7:42:32 AM
Tonix Pharma (TNXP) To Present At Rodman & Renshaw18th Annual Global Investment Conference 9/7/2016 9:00:58 AM
Tonix Pharma (TNXP) to Stop Testing Lead Pain Drug, Stock Craters 9/6/2016 8:14:09 AM
Tonix Pharma (TNXP) Announces Successful End-Of-Phase II Meeting With FDA For TNX-102 SL In Post-Traumatic Stress Disorder 8/29/2016 8:17:59 AM
Tonix Pharma (TNXP) Presents Poster On The Development Of TNX-102 SL For Post-Traumatic Stress Disorder (PTSD) At The 2016 Military Health System Research Symposium 8/15/2016 9:30:16 AM
Tonix Pharma (TNXP) Reports Second Quarter 2016 Financial Results And Provides Programs Update 8/8/2016 8:13:07 AM